Revolution Medicines (RVMD) Return on Capital Employed Growth (3y) (2023 - 2026)
Revolution Medicines (RVMD) Return on Capital Employed Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -3,782.00 |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 4,853.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,782.00 |
| Dec 31, 2025 | -2,462.00 |
| Sep 30, 2025 | -1,147.00 |
| Jun 30, 2025 | -251.00 |
| Mar 31, 2025 | -233.00 |
| Dec 31, 2024 | -673.00 |
| Sep 30, 2024 | -5,772.00 |
| Jun 30, 2024 | -4,930.00 |
| Mar 31, 2024 | -956.00 |
| Dec 31, 2023 | -1,460.00 |
| Sep 30, 2023 | -1,915.00 |
| Jun 30, 2023 | -1,234.00 |
| Mar 31, 2023 | -914.00 |